Genzyme CEO exercises options, gets $9.3 mln in net proceeds

Oct 31 (Reuters) - Biotechnology company Genzyme Corp's (GENZ.O: Quote, Profile, Research, Stock Buzz) chief executive disclosed in a regulatory filing that he recently exercised his options to buy 208,749 shares and sold them in the open market for about $15.4 million.

Henri Termeer said he exercised his options to acquire the shares at $29.44 and sold them on Oct. 29 and Oct. 30 at prices ranging from $73.53 to $75.06. Termeer received about $9.3 million in net proceeds.

After the transactions, he directly owns 631,934 shares of Genzyme.

(Reporting by Shivani Singh in Bangalore)

((Editing by Himani Sarkar; Reuters Messaging: shivani.singh.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: GENZYME TERMEER/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBNG137030